- Home
- IMCR vs SCS Comparison
IMCR vs SCS Comparison
Compare IMCR & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- SCS
- Stock Information
- Founded
- IMCR 2008
- SCS 1912
- Country
- IMCR United Kingdom
- SCS United States
- Employees
- IMCR N/A
- SCS N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- SCS Office Equipment/Supplies/Services
- Sector
- IMCR Health Care
- SCS Consumer Discretionary
- Exchange
- IMCR Nasdaq
- SCS Nasdaq
- Market Cap
- IMCR 1.5B
- SCS 1.2B
- IPO Year
- IMCR 2021
- SCS 1998
- Fundamental
- Price
- IMCR $32.77
- SCS $11.05
- Analyst Decision
- IMCR Buy
- SCS Buy
- Analyst Count
- IMCR 10
- SCS 1
- Target Price
- IMCR $58.13
- SCS $16.00
- AVG Volume (30 Days)
- IMCR 445.1K
- SCS 1.1M
- Earning Date
- IMCR 08-07-2025
- SCS 06-25-2025
- Dividend Yield
- IMCR N/A
- SCS 3.62%
- EPS Growth
- IMCR N/A
- SCS 37.12
- EPS
- IMCR N/A
- SCS 1.04
- Revenue
- IMCR $333,581,000.00
- SCS $3,217,700,000.00
- Revenue This Year
- IMCR $26.82
- SCS $4.20
- Revenue Next Year
- IMCR $8.15
- SCS $4.09
- P/E Ratio
- IMCR N/A
- SCS $10.62
- Revenue Growth
- IMCR 25.75
- SCS 2.64
- 52 Week Low
- IMCR $23.15
- SCS $9.32
- 52 Week High
- IMCR $41.54
- SCS $14.74
- Technical
- Relative Strength Index (RSI)
- IMCR 45.73
- SCS 50.76
- Support Level
- IMCR $30.76
- SCS $9.70
- Resistance Level
- IMCR $32.55
- SCS $10.99
- Average True Range (ATR)
- IMCR 1.39
- SCS 0.37
- MACD
- IMCR -0.41
- SCS 0.01
- Stochastic Oscillator
- IMCR 19.09
- SCS 60.08
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.